Aligos Therapeutics Inc
NASDAQ:ALGS

Watchlist Manager
Aligos Therapeutics Inc Logo
Aligos Therapeutics Inc
NASDAQ:ALGS
Watchlist
Price: 39.84 USD 3.89%
Market Cap: 143m USD
Have any thoughts about
Aligos Therapeutics Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
Aligos Therapeutics Inc

Current Assets 79.8m
Cash & Short-Term Investments 74.9m
Other Current Assets 4.9m
Non-Current Assets 8.6m
PP&E 8m
Other Non-Current Assets 635k
Current Liabilities 21m
Accounts Payable 2.7m
Accrued Liabilities 14.8m
Other Current Liabilities 3.4m
Non-Current Liabilities 17.4m
Long-Term Debt 188k
Other Non-Current Liabilities 17.2m

Balance Sheet
Aligos Therapeutics Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
24
70
220
187
81
136
Cash Equivalents
24
70
220
187
81
136
Short-Term Investments
67
48
23
4
45
0
Other Current Assets
2
3
7
14
8
5
Total Current Assets
92
120
250
204
134
141
PP&E Net
15
16
15
15
13
10
PP&E Gross
15
16
15
15
13
10
Accumulated Depreciation
0
2
4
7
10
11
Long-Term Investments
0
10
0
15
0
0
Other Long-Term Assets
0
0
0
1
1
1
Total Assets
108
N/A
147
+36%
265
+81%
235
-11%
147
-38%
152
+3%
Liabilities
Accounts Payable
3
4
3
3
5
3
Accrued Liabilities
4
9
18
27
18
17
Short-Term Debt
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
Other Current Liabilities
0
1
9
9
11
4
Total Current Liabilities
8
14
30
39
33
24
Long-Term Debt
0
3
1
0
0
0
Other Liabilities
13
12
15
11
9
35
Total Liabilities
21
N/A
29
+40%
45
+55%
51
+12%
43
-15%
59
+39%
Equity
Common Stock
101
182
0
0
0
0
Retained Earnings
14
66
175
303
399
487
Additional Paid In Capital
0
1
395
487
503
578
Other Equity
0
0
0
1
0
1
Total Equity
87
N/A
117
+35%
220
+88%
185
-16%
104
-44%
92
-11%
Total Liabilities & Equity
108
N/A
147
+36%
265
+81%
235
-11%
147
-38%
152
+3%
Shares Outstanding
Common Shares Outstanding
37
37
40
43
43
6

See Also

Discover More